Dr. Kishore Vipperla, MD

Dr. Vipperla practices at Hillcrest Medical Center in Tulsa, Oklahoma, part of Ardent Health.

Dr. Vipperla's NPI, 1669663811, was assigned on August 5, 2007. Dr. Vipperla holds Oklahoma license 38015.

Dr. Vipperla's primary practice is Hillcrest Medical Center, at 1120 South Utica Avenue, Tulsa, OK 74104 in Tulsa County. The practice phone is (918) 579-1000.

Dr. Vipperla's primary practice is Hillcrest Medical Center in Tulsa, Oklahoma, part of Ardent Health. Dr. Vipperla is also affiliated with Hillcrest Hospital South. The medical group on file is Utica Park Clinic. Dmand AI also links Dr. Vipperla to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vipperla practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Vipperla's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Vipperla's licenses on file in 2 states: Oklahoma and Pennsylvania.

CMS data shows 623 Medicare services from Dr. Vipperla across 17 procedure codes in 2024, for 379 Medicare patients. Medicare paid $63,303 for them.

CMS counts 379 Medicare patients who saw Dr. Vipperla in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vipperla's median patient age at 62, with 55% women.

In 2024, Dr. Vipperla wrote 1,098 Medicare Part D claims for 499 patients. 74% of them were for generic drugs. CMS names the drug for 895 of them, across 16 drugs with 11 or more claims each, at $79,781 in total drug cost. In 2023, CMS named 799 claims across 16 drugs.

Dr. Vipperla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vipperla as offering telehealth. CMS counts 467 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Vipperla, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Vipperla, published from 2012 to 2022. 2013 was the busiest year, with 4. The most frequent topics are Pancreatitis, Chronic, Tomography, X-Ray Computed and Diabetes Mellitus. Dr. Vipperla has published most often in Pancreatology. Dr. Vipperla's most frequent co-authors are Georgios I. Papachristou, MD, Randall E. Brand and Rohit R. Das, MD, MPH.

CMS Open Payments shows 128 general payments to Dr. Vipperla from 22 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $1,880.